CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
Tag: HPBCD
CDs in biodegradation-based soil remediation under aerobic conditions
The non-toxic, biodegradable cyclodextrins (CDs) can solubilize poorly soluble organic contaminants such as PAHs, PCBs, chlorinated solvents, etc. via molecular
CTD Announces Partnership with United BioSource
CTD Holdings, a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need,
CD-enabled elektrokinetic extraction of pollutants from soil
The electrokinetic extraction process removes metals and polar organic contaminants from low-permeability soil, mud, sludge, and marine dredging by applying
Cyclodextrins in veterinary medicine (Part 1)
It is well known, that cyclodextrins have many different applications. Can they be used in veterinary medicine? Well, yes and
FDA Approved Development of VAR 200 for Treatment of FSGS
Variant Pharmaceuticals, Inc received US Food and Drug Administration (FDA) has approval for the development of VAR 200 (2-hydroxypropyl-β-cyclodextrin, or
Antibiotics degradation products against Alzheimer’s disease
A recent paper in Cell Reports published an interesting finding: polymeric degradation products (compound X and Z, respectively) of antibiotics
HPBCD treatment of Alzheimer’s disease
CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with
How air fresheners work?
Chemical Engineering News has published the above drawing by Andy Brunning, author of the popular graphics blog Compound Interest, on
Cyclodextrins against skin aging
Since the last review in the Cyclodextrin News summarizing the anti aging effects of retinol (Vitamin A) and its derivatives,